Insider Trading News

Baker Bros. Advisors LP, a director at Madrigal Pharmaceuticals, Inc., purchases $35M of stock

By Insider Stock Trader Newsroom1 min readInsider Stock Trader
Baker Bros. Advisors LP, a director at Madrigal Pharmaceuticals, Inc., purchases $35M of stockBaker Bros. Advisors LP, a director at Madrigal Pharmaceuticals, Inc., purchases $35M of stock

An open-market purchase between Nov 4 and Nov 6, reported to the SEC on Nov 6. Information only, not investment advice.

Insider buying at Madrigal Pharmaceuticals, Inc.: Baker Bros. Advisors LP, a director, added 91,806 shares between Nov 4 and Nov 6 for $35 million, at an average of $381.49 a share, a Form 4 filed on Nov 6 shows.

The purchase was made in the open market, not through an award, an option exercise or a plan. After the trade, the filing lists 2,040,682 shares held.

The trade was reported within two business days, as Section 16 requires.

Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.

The purchase
CompanyMadrigal Pharmaceuticals, Inc. (MDGL)
InsiderBaker Bros. Advisors LP
RoleDirector
TransactionOpen-market purchase (code P)
Shares91,806
Average price$381.49
Value$35,023,032
Trade datesNov 4 to Nov 6, 2026
Filed with the SECNov 6, 2026, 5:30 PM ET
Shares held after2,040,682
OwnershipIndirect
Rule 10b5-1 planNot marked in the filing

View this Form 4 in Insider Stock Trader

View the Form 4 on SEC.gov

Browse the insider trading newsroom · Read more MDGL insider trading news

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.